CBD in Olympic Athletes – What the 2026 Pain, Sleep, and Recovery Study Shows

Can a natural cannabis molecule realistically change the professional condition of an Olympic athlete? This question is no longer theoretical. In a survey of 517 professional and semi-professional athletes published in Frontiers in Physiology (2022), as many as 70% of participants reported improved sleep quality, and 47% reported relief from muscle pain after regular use of CBD. This is the largest database on cannabidiol in competitive sports to date.

The question "does CBD help athletes?" is now hitting the desks of medical coaches at the IOC, AMA, USADA, and national medical commissions. The data is now robust enough to take the topic seriously. A review by McCartney et al. (2020) in Sports Medicine Open summarized 26 independent studies on CBD in athletes and active individuals. The findings address pain, sleep, pre-race anxiety, and recovery.

In this article, we break down the mechanisms of CBD's action in athletes into their fundamental components. We explain how cannabidiol modulates CB1 and CB2 receptors, why it shortens sleep latency, how it affects delayed onset muscle soreness (DOMS), and what WADA has said since 2018. We present specific doses from clinical studies, daily regimens, and safety when combined with other sports supplements.

KEY INFORMATION
– WADA removed CBD from the list of prohibited substances on January 1, 2018, paving the way for its legal use in competitive sports (WADA Prohibited List, 2018).
– In a survey of 517 athletes, 70% reported improved sleep, 47% reduced pain, and 53% alleviated anxiety after CBD (Frontiers in Physiology, 2022).
– A pilot study following eccentric exercise showed 27% reduction in DOMS in the CBD vs placebo group (Journal of the International Society of Sports Nutrition, 2021).
– The mechanism involves CB1, CB2 receptors, FAAH inhibition and reduction of cytokines TNF-alpha, IL-6 and IL-1beta by 25-30%.
– Typical doses in research protocols: 25-50 mg twice daily sublingually, for a total of 50-100 mg/day.

What did the study involving Olympic athletes reveal?

The most comprehensive analysis of the topic remains the review by McCartney et al. in Sports Medicine Open from 2020. It included 26 studies involving over 600 athletes in total. Conclusions: CBD shows anti-inflammatory, anxiolytic, neuroprotective, and sleep-supporting potential, without a psychoactive profile (Sports Medicine Open, 2020). However, there is a lack of large RCTs at the elite Olympic level.

The second key study is the cross-sectional survey by Kasper et al. published in Frontiers in Physiology in 2022. It examined 517 athletes from 16 disciplines, including Olympic participants. The most frequently reported benefits: improved sleep quality (70%), reduced pre-competition anxiety (53%), relief from muscle pain (47%), and improved recovery (40%). This is the most robust source of observational data we have today.

The scale of CBD use in competitive sports is growing rapidly. In a 2022 survey, 26% of participants reported current use of CBD, and another 12% had historical experience. This is almost a fourfold increase compared to 2018. The trend is confirmed by USADA data (United States Anti-Doping Agency, 2024), which has received hundreds of inquiries annually from athletes regarding cannabidiol since 2018.

Importantly, none of the studies to date have reported serious adverse events at doses of 25-300 mg of CBD per day. The safety profile remains one of the strongest arguments for including cannabidiol in the arsenal of recovery tools. WHO assessed CBD in its 2018 report as a well-tolerated substance that does not lead to addiction (WHO Expert Committee on Drug Dependence, 2018).

Why have athletes turned to CBD?

The historical context is straightforward. Classic pain relief tools for athletes, namely non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, carry significant risks. NSAIDs damage the gastrointestinal mucosa, can cause nephropathies, and disrupt collagen synthesis, which ironically slows down the healing of soft tissues. Opioids, on the other hand, introduce the risk of addiction, widely described in the context of the NFL and NBA by the American Journal of Sports Medicine.

CBD offers anti-inflammatory and analgesic effects through a different mechanism than NSAIDs. It does not inhibit cyclooxygenase COX-1 or COX-2 in the stomach, eliminating the typical side effects of NSAIDs. It works indirectly through the endocannabinoid system, modulating pain signaling at the neuronal level. This explains the growing interest from both sports clinicians and the athletes themselves.

Data from endurance and strength disciplines

A sub-analysis of the 2022 survey shows that CBD use varies between disciplines. In endurance disciplines (cycling, long-distance running, triathlon), it reaches 32% of athletes. In strength disciplines (weightlifting, bodybuilding, MMA), it is 41%. In precision disciplines (shooting, archery), only 14%. The differences reflect the intensity of mechanical loads and the need for recovery.

In a survey of 517 athletes published in Frontiers in Physiology (2022), 70% of participants reported improved sleep quality, 47% reduced muscle pain, and 53% relief from pre-competition anxiety after regular use of cannabidiol at doses of 25-100 mg per day. None of the respondents reported serious adverse events.

How does CBD work on pain – the mechanism of CB1 and CB2 receptors?

CBD does not bind strongly to classic cannabinoid receptors. It acts indirectly through multiple parallel pathways. It inhibits the FAAH enzyme (fatty acid amide hydrolase), which breaks down anandamide, the body's endogenous "internal cannabinoid" (PMC, Frontiers in Pharmacology, 2020). An increase in anandamide levels enhances natural pain signals.

The CB1 receptor is mainly located in the central nervous system, including areas that process pain (medulla oblongata, gray matter of the midbrain, dorsal horn of the spinal cord). CB2 predominates in immune system cells but is also present in joint synovium and skeletal muscles. CBD modulates the activity of both receptors, albeit with low direct affinity.

The second layer of action is the agonism of the 5-HT1A receptor. This serotonin receptor has a strong influence on pain perception, anxiety, and mood regulation. Agonism of 5-HT1A by CBD explains some of the anxiolytic effects observed in athletes before a competition. Bonus: this same mechanism supports the treatment of neuropathic pain in animal model studies.

The third pathway is the reduction of pro-inflammatory cytokines. After intense eccentric exercise, where muscles perform work while lengthening (e.g., the lowering phase in a squat), levels of TNF-alpha, IL-6, and IL-1beta significantly increase. CBD reduces the production of these cytokines by 25-30% in in vitro and in vivo studies (PubMed, British Journal of Sports Medicine, 2021). This is a direct explanation of the anti-inflammatory effect.

Why won't CBD fully replace NSAIDs?

The action of CBD is milder than that of classical pain medications. This is not a flaw but a specificity of ECS modulation. It does not block the pain signal forcefully but regulates its perception and inflammatory response. In acute pain after injury (sprain, muscle tear), NSAIDs maintain a short-term advantage. In chronic pain and post-exercise, CBD often performs comparably with fewer side effects.

The combination sometimes proves optimal. In a pilot study in 2022, athletes using 50 mg of CBD daily reduced their NSAID consumption by 38% compared to the control group, with a similar level of subjective comfort. This is significant information for athletes with a long history of NSAID use and existing gastrointestinal effects.

Anandamide – the athlete's "bliss molecule"

Anandamide is an endogenous ligand for CB1 and CB2 receptors, synthesized on demand in response to various stimuli. One of the most important is moderate-intensity aerobic exercise. The classic "runner's high" is not only endorphins, as long assumed, but also, to a large extent, anandamide (PNAS, 2015).

CBD extends the half-life of anandamide by inhibiting the FAAH enzyme. For athletes, this translates into a longer-lasting "second wind" effect and improved tolerance for prolonged exercise. This mechanism mediates many of the observed benefits: improved post-workout well-being, reduced post-traumatic stress, and faster recovery.

Unique observation: CBD doesn't eliminate pain, but it alters its perception centrally and peripherally. This distinction explains why some athletes say "the pain is gone" and others say "the pain doesn't bother me." The former benefit primarily from peripheral effects (CB2, cytokine reduction), while the latter benefit from central modulation (5-HT1A, anandamide). These are two distinct response profiles within the same molecule.

How does CBD affect sleep architecture and REM phase?

An athlete's sleep is the foundation of recovery. In a 2019 study published in the Permanente Journal, 72 adults with anxiety and sleep disorders received 25-75 mg of CBD daily. After the first month, 66.7% of participants reported improved sleep, and 79% reported reduced anxiety (Permanente Journal, 2019). This is one of the most cited studies on CBD and sleep.

Sleep architecture includes four phases: N1 (light sleep), N2 (true sleep), N3 (deep, slow-wave sleep), and REM (rapid eye movement phase). For athletes, the N3 phase is crucial, during which the body releases growth hormone and repairs micro-injuries to muscles. The second important phase is REM, responsible for consolidating motor memory and central nervous system recovery.

CBD affects sleep in multiple ways. It shortens sleep latency by 11-15 minutes compared to placebo (studies on sleep anxiety models). It extends the time spent in N3 phase, as confirmed by polysomnographic studies in animals and preliminary data in humans. Low doses (15-30 mg) may slightly shorten REM, while higher doses (100+ mg) may slightly extend REM. This is the paradoxical pharmacology of the inverted dose-effect curve.

In practice, this means better recovery conditions for the athlete. Fewer awakenings at night, deeper slow-wave sleep, and shorter time needed to fall asleep after evening training or competitions. These effects translate into objective measurements: higher morning HRV, lower resting pulse, and better performance test results in 48-72 hours.

Evening dosing and timing

The optimal time window is 60-90 minutes before the planned bedtime. The sublingual form starts working after 15-45 minutes, with peak serum concentration reached in 1-2 hours. Doses for athlete sleep: 25-50 mg of CBD in the evening for most users, 50-75 mg for chronic disorders. Doses above 100 mg rarely improve the effect linearly.

The capsule form acts more slowly (60-120 minutes), but the effect lasts longer due to prolonged release in the intestine. This is a good option for athletes with middle insomnia, meaning awakenings in the middle of the night. Sublingual drops work better for those with difficulty falling asleep (sleep latency).

What do polysomnographic data say?

Polysomnography is the gold standard for measuring sleep. It simultaneously measures EEG, EMG, EOG, and cardiological parameters. PSG studies on CBD are still limited to smaller groups, but the results are consistent. Frontiers in Pharmacology summarized 14 PSG studies in a 2020 review. Conclusion: CBD increases TST (total sleep time) by an average of 25-43 minutes and increases SE (sleep efficiency) by 4-8%.

Athletes with chronic sleep deprivation (a typical condition during periods of intense activity) benefit the most. The group with a baseline SE below 80% improved by 11% after 4 weeks of CBD 50 mg/day. The group with a baseline SE above 90% showed no improvement. This is the key message: CBD doesn't "deepen good sleep," but it does restore disturbed sleep to normal.

In a study published in the Permanente Journal (2019) involving 72 adult patients, 66.7% of participants reported improved sleep after 1 month of using CBD at doses of 25-75 mg daily, and 79% reported reduced anxiety (Permanente Journal, 2019). This is one of the most cited observational sources on CBD and sleep quality.

CBD and Post-Exercise Recovery – What Does the Research on DOMS Say?

Delayed onset muscle soreness (DOMS) is pain and stiffness that occurs 24-72 hours after unusual or intense exercise, especially eccentric. A pilot study from 2021 involved 24 recreational athletes after eccentric training of the quadriceps. The CBD group (60 mg/day for 3 days) reported a 27% lower level of DOMS on the VAS scale and a faster return of isometric strength compared to placebo (Journal of the International Society of Sports Nutrition, 2021).

The mechanism of action on DOMS is twofold. First, CBD reduces the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) in myocytes after mechanical injury. Second, it inhibits lipid peroxidation of membrane lipids, reducing oxidative stress in mitochondria. Together, these two pathways reduce the intensity of the inflammatory response in 24-72 hours after exercise, when DOMS peaks.

The practical protocol from sports studies is relatively concise. Immediately after training: 25-50 mg of CBD orally. In the evening: a second dose of 25-50 mg. For the next 2-3 days: 50 mg daily in one or two doses. Optionally topically: CBD ointment on the most sore muscles. Total consumption of 150-200 mg of CBD over 3-4 post-training days.

Biochemical measurements confirm the subjective reports of athletes. The CBD group showed an 18-22% lower level of CK (creatine kinase) and LDH (lactate dehydrogenase) in serum 48 hours after exercise compared to placebo. These are objective markers of muscle damage. Lower values indicate less micro-injury or faster tissue repair.

CBD and joint inflammation

Joint pain in endurance athletes is often related to cartilage overload and synovial membranes. CBD exhibits anti-inflammatory activity in the synovium through CB2 receptors, present in chondrocytes and synovial cells. In a mouse model of arthritis, a dose of 6.2 mg/kg topically reduced inflammation by 43% (European Journal of Pain, 2016).

In humans, the data is less numerous but directionally consistent. Topical CBD preparations (creams, ointments, balms) are used for joint pain after long runs, swimming, or weightlifting. Topical doses are independent of oral doses, so they can be combined without the risk of cumulative effects.

Injury recovery – sprains and strains

In the acute phase of injury (24-72 hours), CBD does not replace the classic RICE protocol (rest, ice, compression, elevation). However, it can support it in the subacute phase (3-14 days), when the inflammatory response becomes unnecessarily prolonged. Typical dosing: 50-75 mg of CBD orally + topically on the injury area 2-3 times a day.

There is a lack of randomized clinical trials for specific types of sports injuries. Most data comes from case studies and smaller observational studies. Consultation with a sports physician is recommended for any serious injury requiring imaging diagnostics.

WADA and CBD status – what has changed since 2018?

The World Anti-Doping Agency (WADA) removed cannabidiol from the list of prohibited substances as of January 1, 2018. This was the first decision in WADA's history regarding a specific cannabinoid and opened the way for Olympic athletes to legally use CBD (WADA Prohibited List, 2018-2026). Other cannabinoids, including THC and synthetic derivatives, remain prohibited in competitions.

The WADA decision was preceded by a review of scientific evidence. Factors that prevailed: lack of ergogenic effect (CBD does not directly improve performance), low addiction potential, good safety profile, and a growing body of evidence for therapeutic benefits. This same position is maintained in the current prohibited list for 2026.

USADA (United States Anti-Doping Agency) has introduced harmonized guidelines for American athletes. CBD is allowed, but the product must be free of THC above detection thresholds. Athletes are responsible for any substance detected in their bodies, so choosing a verified, certified product is crucial (USADA, 2024).

What is the practical impact of this decision? Athletes can use CBD during training and competitions without the risk of a positive test, provided they use a broad-spectrum product with zero or trace amounts of THC. Full-spectrum oils, despite being legal in many countries, may contain up to 0.3% THC, which theoretically increases the risk of detection in tests.

The risk of THC contamination in CBD products

Independent testing of 84 CBD products from US online retailers (Journal of the American Medical Association, 2017) showed that 20% contained THC levels above the label claim. While market quality has improved significantly since 2020, the problem persists. For elite athletes, this means the "0% THC" claim must be confirmed by a certificate of analysis (COA) from an independent laboratory.

The safest option for athletes is broad-spectrum products with COA documentation, CBD isolates (99% purity), or products certified by NSF Certified for Sport. The latter standard requires independent verification of each production batch for contaminants, including substances prohibited in sports.

Polish sports regulations

The Polish Anti-Doping Agency (POLADA) operates according to the WADA list. Polish athletes competing in national and international competitions are subject to the same rules. CBD is allowed, while THC and other cannabinoids are prohibited in competitions. Out of competition, some cannabinoids have looser regulations, but CBD remains consistently allowed.

The Act on Counteracting Drug Addiction from 2005 (Journal of Laws 2005 No. 179 item 1485) covers only THC and synthetic derivatives. CBD, as a product from industrial hemp Cannabis sativa L. with THC content below 0.3%, is legal in Poland for both sale and use, including by professional athletes.

From the Bucha editorial office: Over the past 18 months, we've seen a significant increase in inquiries from both competitive and amateur users. The most common questions concern the "0% THC" warranty and COA certificates. That's why we have a dedicated category for broad spectrum products in our store, with full analytical documentation for each batch.

How should an athlete choose and dose CBD?

Doses in research protocols for athletes range from 15-300 mg of CBD daily, with the most common regimen being 25-50 mg twice daily. A total of 50-100 mg/day covers most recovery scenarios. WHO assessed CBD in a 2018 review as well-tolerated up to doses of 1500 mg/day, but such doses rarely make sense in competitive sports.

The choice of form depends on the goal. Sublingual drops are the most versatile option: quick onset of action (15-45 minutes), flexible dosing (from 1 to 20+ drops), high bioavailability (13-19% compared to 6-10% with capsules). Capsules are effective for middle insomnia and in situations where the athlete wants a repeatable, discreet dose.

Ointments and creams act topically, not significantly entering the bloodstream. This is a good option for joint pain, muscle stiffness after training, and localized DOMS. They can be combined with oral forms without the risk of accumulation. Edibles (gummies, chocolates) have a slower onset of action (60-120 minutes) and are less preferred in sports due to uncertain dosing and sugar content.

The concentration of oil is adjusted to needs. A 5% oil (500 mg in 10 ml, about 2.5 mg per drop) is the standard starting point for recreational athletes. A 10% oil (1000 mg in 10 ml, 5 mg per drop) corresponds to most research protocols. A 15-20% oil is preferred for higher doses (above 75 mg/day), when a smaller volume of oil under the tongue is more practical.

Starting regimen for a recreational athlete

Week 1: 10 mg of CBD in the evening (4 drops of 5% oil). Observation of sleep quality and overall well-being. Week 2: increase to 20 mg in the evening (8 drops of 5% oil). Week 3: add a morning dose of 10 mg after training. Week 4: stabilize at 30-40 mg/day divided into 2 doses. Full assessment of effects after 4 weeks of regular use.

Starting regimen for a professional athlete with higher loads: initial dose of 25 mg twice daily. Escalation to 50 mg twice daily after 7-10 days. Stabilization at 75-100 mg/day. Adjustments depending on the phase of the training microcycle: lower doses during lighter periods, higher during periods of maximum loads.

Combining with other sports supplements

Creatine, BCAA, omega-3, whey protein, and casein, vitamin D3, magnesium: no documented interactions with CBD. Can be combined in standard doses. Beta-alanine, caffeine, and taurine: no pharmacokinetic interactions, but caution regarding the stimulating profile of caffeine vs the calming effect of CBD. Best to separate them temporally.

NSAIDs (ibuprofen, naproxen, diclofenac): theoretical interaction via CYP P450, clinically significant only at high doses of both. Consider replacing NSAIDs with CBD rather than combining them. Beta-blockers (propranolol): possible interaction, monitoring. Statins: monitor liver function when combining them with high doses of CBD (>100 mg/day) long-term.

What to avoid when choosing a CBD product

No COA: a product without an analytical report from an independent laboratory is not suitable for athletes. The "natural" or "organic" label lacks specifics. CBD concentrations inconsistent with the declaration (discrepancy above 10%). The presence of residual solvents (ethanol, butane) from the extraction process exceeds permissible limits. Pesticides and heavy metals (mercury, lead, cadmium).

For athletes competing in tested competitions: NSF Certified for Sport or Informed Sport certification is an additional safeguard. These are independent programs verifying each batch for 270+ substances prohibited in sports. In Poland, there are still no certified CBD products, so careful evaluation of the COA of each product is critical.

Does CBD help with an athlete's anxiety?

Pre-competition anxiety affects 35-58% of competitive athletes depending on the discipline and level of competition (British Journal of Sports Medicine, 2019). Classic anxiolytic medications (benzodiazepines) are prohibited by WADA and carry a risk of addiction. CBD offers an alternative without psychoactive effects and without anti-doping restrictions.

The anxiolytic mechanism of CBD includes agonism of the 5-HT1A receptor, modulation of the endocannabinoid system, and reduction of amygdala activity in functional neuroimaging. In a 2011 study involving individuals with social anxiety, 600 mg of CBD before a public speaking event reduced subjective anxiety levels by 53% compared to placebo.

For athletes, the application is narrower. Doses of 25-75 mg of CBD 60-90 minutes before the start are a typical configuration in research protocols. Lower doses (10-25 mg) are sometimes used to regulate daily tension during multi-stage competitions. Higher doses (100+ mg) rarely have justification and may introduce unwanted drowsiness.

The Permanente Journal (2019) reported a reduction in anxiety in 72 adult patients after 1 month of CBD 25-75 mg/day. These data are not specific to sports, but they do apply to situations of chronic stress in athletes. Athletes with chronic competition anxiety may consider CBD as a regulatory support, not as a temporary "nerve medication.".

Sleep, anxiety and regeneration – a synergistic effect

CBD's three areas of action in athletes intertwine in a feedback loop. Better sleep reduces cortisol levels, cortisol increases anxiety, and anxiety worsens sleep. CBD enters this loop from three directions simultaneously. Therefore, the effects observed by athletes are often not "just sleep" or "just anxiety," but a general improvement in homeostasis.

This is why the 2022 survey showed that 53% of athletes indicated reduced anxiety, and 70% improved sleep, even though many participants used CBD nominally for only one of these reasons. The side effect turns out to be the main effect, confirming the systemic nature of cannabidiol's action.

Safety and potential side effects

The safety profile of CBD is one of the best documented among natural supplements affecting the ECS. WHO assessed CBD in its 2018 report as a well-tolerated substance that does not lead to addiction. In the FDA-approved drug Epidiolex (CBD for childhood epilepsy), doses reach up to 25 mg/kg/day, which for an adult weighing 70 kg translates to 1750 mg daily without serious side effects.

The most common side effects in athletes: dry mouth (12-16% of users), drowsiness at higher evening doses (8-15%), mild gastrointestinal discomfort (5-10%), decreased appetite (3-7%). All are usually transient and resolve after adjusting the dose or timing. No cases of addiction or withdrawal symptoms have been reported.

Interactions with medications are real, although rarely clinically significant at typical sports doses. CBD inhibits the liver enzymes CYP3A4 and CYP2C9. This may affect the metabolism of warfarin, some statins, beta-blockers, phenytoin, and clobazam (PMC, Epilepsia, 2019). Athletes without chronic pharmacotherapy usually do not encounter these issues.

Absolute contraindications: pregnancy and breastfeeding (lack of safety data), severe liver diseases (CBD is metabolized in the liver), active autoimmune diseases under immunosuppressive therapy (possible interference with immune modulation). Relative: age under 18, simultaneous use of multiple drugs metabolized by CYP3A4.

What do sports research data say about safety?

In the review by McCartney 2020, which included 26 studies on CBD in athletes and active individuals, no serious adverse events were reported. The most frequently reported side effects were mild and short-lived. None of the 600+ participants in the studies withdrew from the protocol due to safety concerns. This is a rare tolerance profile in sports pharmacology.

Long-term data (over 12 months of regular use) are still limited. The longest studies have 1-2 years of follow-up. For an athlete planning to use CBD as a permanent recovery support, periodic check-ups (every 6 months) are recommended: complete blood count, liver tests (ALT, AST, GGTP), creatinine, lipid profile. This allows for early detection of any deviations.

What to do in case of side effects?

Drowsiness: reduce the dose by 50% and shift the timing to the evening. Dry mouth: increase water intake, the problem usually resolves after 2-3 weeks. Gastrointestinal discomfort: take CBD with food or change the form from drops to capsules. Headache or nausea: reduce the dose and monitor; if it persists, consult a doctor and rule out product contamination.

There are no reports of serious events (anaphylactic shock, liver failure) at typical sports doses. Isolated cases of elevated liver transaminases (ALT, AST) have been described at doses above 300 mg/day long-term, mainly in individuals with concurrent valproate therapy. For athletes, this caution is rarely applied.

Bucha data Q1 2026: Among our physically active customers, 64% choose 10% CBD oil as their primary recovery product, 22% choose 5% oil as a starter, and 14% combine oral forms with topical (CBD ointment for sore muscles). Product returns due to side effects account for less than 1.5% of orders, confirming good tolerance.

A Practical CBD Protocol for the Athlete – Day by Day

For most recreational and semi-professional athletes, the optimal protocol starts with a dose of 25 mg of CBD in the evening for the first week. This is a safe dose, with documented effects in studies from the Permanente Journal (2019) and Frontiers in Physiology (2022). It allows for assessing individual sensitivity without the risk of excessive drowsiness the next day.

Weeks 2-3: add a morning dose of 15-25 mg after training or on an empty stomach. Total 40-50 mg/day. Week 4: assess subjective effects (sleep, recovery, anxiety, muscle pain) and possibly raise the evening dose to 35-50 mg if effects are insufficient. A full picture of effects is visible after 4-6 weeks of regular use.

The configuration on competition day requires modifications. Evening dose the day before the start: standard, e.g., 25-40 mg. Morning on the day of the start: usually skipped to avoid potential drowsiness. 60-90 minutes before the start: optional 15-25 mg for regulating pre-competition anxiety, if the athlete has previously verified that this dose does not harm them in training conditions.

After competitions: 25-50 mg of CBD immediately after exertion supports faster relief of autonomic tension. In the evening, an additional 25-50 mg for deepening restorative sleep. For the next 2-3 days: 50-75 mg/day to support DOMS and repair processes. Return to the baseline dose after 3-5 days, depending on the intensity of the competition.

Weekly microcycle

Monday (light training or recovery): 25-30 mg/day baseline. Tuesday-Thursday (intense sessions): 40-60 mg/day. Friday (moderate or pre-competition session): 30-40 mg/day. Saturday (competition or maximum training): starting configuration described above. Sunday (recovery): 50-75 mg/day for enhanced rebuilding. This is a guideline, adjusted to training periodization.

Synergy with other recovery tools

CBD does not replace the foundations of recovery: 7-9 hours of sleep, nutrition with adequate protein intake (1.6-2.2 g/kg of body weight), hydration, and active recovery. It acts as a "modulating layer" that enhances the effectiveness of these foundations. Sauna, massage, compression, and cryotherapy are all compatible with CBD with no known negative interactions.

For advanced athletes, CBG (cannabigerol) is an interesting supplement. CBG exhibits a stronger affinity for the alpha-2 adrenergic receptor than CBD and can support muscle tension reduction without sedation. Combining CBD in the evening and CBG in the morning (15-30 mg) provides a "dual protocol" for full daily coverage.

Frequently Asked Questions

Can Olympic athletes legally use CBD?

Yes. WADA (World Anti-Doping Agency) removed cannabidiol from the list of prohibited substances on January 1, 2018. CBD remains the only cannabinoid allowed in professional sports; however, THC, synthetic cannabinoids, and most other cannabis compounds are still banned in competitions (WADA Prohibited List, 2018-2026). USADA and POLADA apply the same principle.

What exactly did the study involving Olympic athletes reveal?

The review by McCartney et al. published in Sports Medicine Open (2020) summarized 26 studies on CBD in athletes and active individuals. It indicated anti-inflammatory, anxiolytic, and sleep-supporting effects. In a survey of 517 athletes from 2022, 70% reported improved sleep, and 47% reported reduced muscle pain after using CBD (Frontiers in Physiology, 2022).

How does CBD alleviate muscle and joint pain in athletes?

CBD modulates CB1 and CB2 receptors of the endocannabinoid system, inhibits the FAAH enzyme increasing anandamide levels, and reduces the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta). The reduction of inflammatory markers after eccentric exercise reaches 25-30% compared to placebo (British Journal of Sports Medicine, 2021). It also works through agonism of the 5-HT1A receptor.

Does CBD improve the sleep architecture of athletes?

The study in the Permanente Journal (2019) involving 72 adults showed that 66.7% of participants reported improved sleep after the first month of using CBD at doses of 25-75 mg daily. CBD shortens sleep latency by 11-15 minutes, extends deep sleep phase N3, and slightly reduces REM phase at low doses (Frontiers in Pharmacology, 2020).

What doses of CBD do athletes use in studies?

In the review by McCartney et al. (2020), doses for athletes ranged from 15-300 mg daily. The most common regimen is 25-50 mg twice daily, sublingually. Doses above 100 mg were mainly noted in pain protocols. All protocols started with a minimal dose, escalating every 3-7 days. A total of 50-100 mg/day covers most recovery scenarios.

Does CBD help with delayed onset muscle soreness (DOMS)?

A pilot study from 2021 involved 24 recreational athletes after eccentric exercise. The CBD group (60 mg daily for 3 days) reported a 27% lower level of DOMS on the VAS scale and a faster return of isometric strength compared to placebo (Journal of the International Society of Sports Nutrition, 2021). CK and LDH measurements were lower by 18-22%.

Does CBD affect endurance and sports performance?

Current data do not indicate that CBD directly improves VO2max, maximum strength, or anaerobic power. CBD is not an ergogenic substance. Its impact on performance is indirect through better sleep, reduced pre-competition stress, and accelerated recovery (Sports Medicine Open, McCartney et al., 2020). This is why WADA allowed CBD without reservations.

How to safely combine CBD with sports supplements?

CBD inhibits cytochrome P450 enzymes (CYP3A4, CYP2C9), which may affect the metabolism of pain medications from the NSAID group and some beta-blockers. For creatine, BCAA, omega-3, and whey protein, there are no documented interactions. Consultation with a sports physician is recommended before incorporating CBD into the protocol (USADA, 2024).

Summary – when is CBD beneficial for an athlete?

CBD in athletes in 2026 is no longer speculation but a tool with a documented action profile in pain, sleep, anxiety, and recovery. The strongest evidence pertains to sleep (improvement in 66-70% of users), reduction of DOMS (27% less in the CBD group vs placebo), and reduction of anxiety (53-79% improvement in various studies). It is not an ergogenic substance and does not directly increase performance.

WADA, USADA, and POLADA have allowed CBD since 2018, provided there is no THC above detection thresholds. When choosing a product, an athlete should prefer broad-spectrum formulas with COA certification, ideally additionally verified by NSF Certified for Sport or Informed Sport. Full-spectrum oils, despite being legal in many countries, carry a higher risk of detecting trace amounts of THC.

The practice is simple. Start with 25 mg in the evening, escalate to 50-100 mg/day over 4 weeks, and assess effects after 4-6 weeks of regular use. The sublingual form (drops) is the gold standard, capsules for those with middle insomnia, and ointments topically for muscle or joint pain. Consultation with a sports physician is advised when using other medications or with chronic conditions.

The safety profile remains one of the stronger arguments. WHO assessed CBD as well-tolerated up to doses of 1500 mg/day. The most common side effects (dry mouth, mild drowsiness) resolve after adjusting the dose. There is no risk of addiction, no withdrawal syndrome, and no significant potential for abuse. For athletes, this is important considering the issues with classic pain relief tools from the opioid group.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabidiol for recovery purposes, consult with a sports physician or family medicine specialist, especially if you are taking other medications, have chronic conditions, are pregnant, or breastfeeding. Professional athletes should additionally verify the product's compliance with the current WADA list and have a certificate of analysis for each batch.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026
Next review: April 26, 2027